RECENT FUNDING
  1. Recent Funding
  2. Investors
  3. Bain Capital Life Sciences
B

Bain Capital Life Sciences portfolio

Bain Capital Life Sciences has 11 portfolio companies on record at Recent Funding, with 3 investments in the last 12 months.

Type: Venture capital.
Portfolio on Recent Funding: 11.
Deals, last 12 months: 3.
Rounds led: 6 of 9.
Capital in their rounds: $1.28B.
Latest deal: Seran Bioscience · Sep 29, 2026.
About this page

It is a venture capital firm based in Boston, US, founded in 2016. It led 6 of the 9 rounds it joined. Its most recent investment on record is Seran Bioscience's Series B+ round in September 2026, alongside Biospring Partners and Vivo Capital. By category, its portfolio leans toward Health and bio (11) and Manufacturing and industrial (2). It has co-invested with GV, Third Rock Ventures and RA Capital Management, most often GV (3 rounds).

About Bain Capital Life Sciences

Firm type: Venture capital.
Headquarters: Boston, US.
Founded: 2016.
Stages: Series B, Series C, Growth, Late Stage.
Sectors: Biotech, Digital Health, Healthtech, Medical Devices.
Portfolio companies: 94.
Exits: 7.
Rounds led: 10.

Fund returns

FundVintageSizeNet IRRTVPIDPIAs of
Bain Capital Life Sciences Fund IV. L.P.2024——0.00x0.00xJun 30, 2025

What Bain Capital Life Sciences invests in

Bain Capital Life Sciences recent investments

How Bain Capital Life Sciences invests

StageDealsCapital in rounds
Series B+ 5 56%$672M
Series A 4 44%$605M
YearDealsCapital in rounds
2022 2 22%$357M
2023 1 11%$245M
2024 2 22%$75M
2025 2 22%$285M
2026 2 22%$315M

Bain Capital Life Sciences portfolio companies

CompanyRound with Bain Capital Life SciencesTotal raisedLatest raise
SSeran Bioscience
Health and bio
Series B+undisclosedSep 29, 2026
Series B+
AAdvanCell
Health and bio
Series B+ · $315M$439.5MJul 15, 2026
Series B+
SSyremis Therapeutics
Health and bio
Series A · $165M$165MDec 18, 2025
Series A
MMerida Biosciences
Health and bio
Series A · $120M · lead$120MMay 7, 2025
Series A
AAngitia Bio
Health and bio
Series B+ · lead$130MFeb 12, 2026
Series B+
AAreteia Therapeutics
Health and bio
Series A · $75M · lead$75MFeb 13, 2024
Series A
AAiolos Bio
Health and bio
Series A · $245M · lead$245MNov 20, 2023
Series A
JJnana Therapeutics
Health and bio
Series B+ · $107M · lead$207MNov 15, 2022
Series B+
EEmalex Biosciences
Health and bio
Series B+ · $250M · lead$285MNov 3, 2022
Series B+
OOMass Therapeutics
Health and bio
backer$422.51MOct 15, 2026
Series B+
CCardurion Pharmaceuticals
Health and bio
backer$260MJul 16, 2024
Series B+

Most frequent co-investors

Similar investors

Investors whose portfolios on Recent Funding center on the same category (Health and bio).

How this is counted

Net returns as reported by the public-pension and foundation LPs invested in each fund.

Firm profile and fund returns: Fundraising Fox Open Dataset v2026-11, CC BY 4.0. Track-record counts are theirs, not Recent Funding's.

Share is of the 9 rounds on Recent Funding that name Bain Capital Life Sciences. Rounds with no announced date are left out of the year split, and "round" is a round whose stage is not on file.

Portfolio companies are the companies on Recent Funding with a round that lists Bain Capital Life Sciences, which is a subset of its real portfolio. API: /api/v1/investors/bain-capital-life-sciences (get a free API key). More: the most active VC firms and new venture capital funds.

Top raises, every week

The week's top funded startups and market insights, in your inbox every Monday.

Unsubscribe anytime · privacy